Johnson & Johnson fourth-quarter earnings down 25%
The company continues to see pressure on sales from staffing shortages at hospitals, which have limited growth in procedures using J&J products, while inflation has boosted expenses.
J&J slashes production of its unpopular COVID-19 shot
A partnership with rival Merck & Co. to help make the shots, forged at the urging of the U.S. government, hasn’t lived up to expectations. The companies are now engaged in arbitration.
China approves sale of Pfizer COVID pill Paxlovid as cases surge, White House denies involvement
The White House says it was not in any way involved in China's approval of Pfizer's COVID-19 pill to treat an anticipated wave of infections.
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults
According to a study published in The New England Journal of Medicine, the Johnson & Johnson's and Merck's vaccines for Ebola created lasting antibodies.
Moderna and Merck team-up to fight melanoma
Vaccine-maker Moderna has partnered with the biopharmaceutical company Merck to create an effective treatment for skin cancer
Ice Cube confirms $9M movie deal taken from him after refusing COVID-19 vaccine
Rapper and actor Ice Cube confirmed he lost a $9 million movie deal with Sony Productions because he refused producers' requests to get vaccinated against COVID-19.
Religious employees allegedly fired for not getting COVID-19 vaccine sue Massachusetts pharmaceutical company
Several religious employees of a Massachusetts pharmaceutical company, who claim they were fired for refusing COVID-19 vaccine have filed a lawsuit, led by Alex Jones' attorney.
Tyson Foods ends COVID-19 vaccine mandate for all employees
The largest meat producer in the U.S., Tyson Foods, ended its COVID-19 vaccine mandate for all employees on Oct. 31, the company said on Monday.
Moderna stock tumbles after quarterly earnings show revenue declines
COVID-19 vaccine maker Moderna's shares fell on Thursday following the release of the company's third-quarter earnings, which showed a decline in revenue.
GSK vaccine for older adults granted FDA priority review
GSK reported strong third-quarter earnings and raised its forecast for 2022. However worries about Zantac litigation kept investors on edge.
Pfizer develops RSV vaccine for infants given during pregnancy
Pfizer announced an experimental vaccine that, when administered during pregnancy, would protect infants from severe illness for up to six months of life.
Pfizer says it's eyeing a $110 to $130 list price for COVID-19 vaccine in U.S.
Pfizer Inc. on Thursday revealed the possible U.S. list price it is eyeing for its adult COVID-19 vaccine doses once the shot hits the commercial market.
Pfizer seeks approval for omicron booster in kids over 5 years old
Pfizer is seeking approval from the FDA for its updated COVID-19 booster shot targeting the omicron variant in kids between the ages of 5 and 11.
Pfizer CEO Albert Bourla tests positive for COVID-19 for second time in less than 2 months
Pfizer Chairman and CEO Albert Bourla said on Saturday that the coronavirus "is still with us" after he tested positive for the second time in less than two months.
Pfizer to supply up to 6 million courses of COVID-19 treatment for lower income countries
Pfizer plans to provide millions of COVID-19 treatment courses for lower income countries. Access to Paxlovid treatment courses has been severely restricted to poorer countries.
CDC approves updated COVID-19 vaccines targeting omicron variant
The Centers for Disease Control and Prevention gave final approval to updated COVID-19 vaccines targeting the dominant omicron variant on Thursday.
Pfizer's new trial vaccine for RSV is over 85% effective in older adults
Pfizer announced on Thursday that a vaccine designed to stop respiratory syncytial virus, or RSV, infections is over 85% effective in older adults.
Bavarian Nordic promises to increase monkeypox vaccine production as supply shrinks
The producer of the only approved monkeypox vaccine is promising to increase the production of vaccine doses as supply falters and cases increase.
Health care workers fired over vaccine mandate awarded $10 million in settlement
Illinois health care workers who filed a lawsuit against their employers' vaccine mandate were awarded a $10 million settlement after arguing the rule violated Title VII.
Pfizer CEO Albert Bourla says he tested positive for COVID-19, has mild symptoms
Pfizer Chairman and CEO Albert Bourla said he was isolating and taking a course of Paxlovid after testing positive for COVID-19 and experiencing mild symptoms.